Literature DB >> 16606372

Inhibition of protein synthesis by activation of NMDA receptors in cultured retinal cells: a new mechanism for the regulation of nitric oxide production.

Marcelo Cossenza1, Daniel V Cadilhe, Rodrigo N Coutinho, Roberto Paes-de-Carvalho.   

Abstract

The synthesis of nitric oxide (NO) is limited by the intracellular availability of L-arginine. Here we show that stimulation of NMDA receptors promotes an increase of intracellular L-arginine which supports an increase in the production of NO. Although L-[3H]arginine uptake measured in cultured chick retina cells incubated in the presence of cycloheximide (CHX, a protein synthesis inhibitor) was inhibited approximately 75% at equilibrium, quantitative thin-layer chromatography analysis showed that free intracellular L-[3H]arginine was six times higher in CHX-treated than in control cultures. Extracellular L-[3H]citrulline levels increased threefold in CHX-treated groups, an effect blocked by NG-nitro-L-arginine, a NO synthase (NOS) inhibitor. NMDA promoted a 40% increase of free intracellular L-[3H]arginine in control cultures, an effect blocked by the NMDA antagonist 2-amino 5-phosphonovaleric acid. In parallel, NMDA promoted a reduction of 40-50% in the incorporation of 35[S]methionine or L-[3H]arginine into proteins. Western blot analysis revealed that NMDA stimulates the phosphorylation of eukaryotic elongation factor 2 (eEF2, a factor involved in protein translation), an effect inhibited by (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK801). In conclusion, we have shown that the stimulation of NMDA receptors promotes an inhibition of protein synthesis and a consequent increase of an intracellular L-arginine pool available for the synthesis of NO. This effect seems to be mediated by activation of eEF2 kinase, a calcium/calmodulin-dependent enzyme which specifically phosphorylates and blocks eEF2. The results raise the possibility that NMDA receptor activation stimulates two different calmodulin-dependent enzymes (eEF2 kinase and NOS) reinforcing local NO production by increasing precursor availability together with NOS catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16606372     DOI: 10.1111/j.1471-4159.2006.03843.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Ex Vivo Model of Spontaneous Neuroretinal Degeneration for Evaluating Stem Cells' Paracrine Properties.

Authors:  Ivan Fernandez-Bueno; Ricardo Usategui-Martin
Journal:  Methods Mol Biol       Date:  2021

2.  Afferent regulation of chicken auditory brainstem neurons: rapid changes in phosphorylation of elongation factor 2.

Authors:  Ethan G McBride; Edwin W Rubel; Yuan Wang
Journal:  J Comp Neurol       Date:  2013-04-01       Impact factor: 3.215

3.  Development of a murine ocular posterior segment explant culture for the study of intravitreous vector delivery.

Authors:  Nora Denk; Vikram Misra; Lynne S Sandmeyer; Bianca B Bauer; Jaswant Singh; George W Forsyth; Bruce H Grahn
Journal:  Can J Vet Res       Date:  2015-01       Impact factor: 1.310

Review 4.  Consolidation and translation regulation.

Authors:  Shunit Gal-Ben-Ari; Justin W Kenney; Hadile Ounalla-Saad; Elham Taha; Orit David; David Levitan; Iness Gildish; Debabrata Panja; Balagopal Pai; Karin Wibrand; T Ian Simpson; Christopher G Proud; Clive R Bramham; J Douglas Armstrong; Kobi Rosenblum
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

5.  Serine/Threonine Phosphatases in LTP: Two B or Not to Be the Protein Synthesis Blocker-Induced Impairment of Early Phase.

Authors:  Alexander V Maltsev; Natalia V Bal; Pavel M Balaban
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

6.  Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina.

Authors:  I Fernandez-Bueno; M T Garcia-Gutierrez; G K Srivastava; M J Gayoso; J M Gonzalo-Orden; J C Pastor
Journal:  Mol Vis       Date:  2013-04-17       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.